Potent EGFR tyrosine kinase inhibitors as anticancer agents

被引：0
|
作者：
Shiao, Hui-Yi [1 ]
Chu, Chang-Ying [1 ]
Hsu, John T. -A. [1 ]
Yeh, Teng-Kuang [1 ]
Hsieh, Hsing-Pang [1 ]
机构：
[1] Natl Hlth Res Inst, Inst Biotechnol & Pharmaceut Res, Zhunan, Miaoli, Taiwan
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2011年 / 241卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
257-MEDI
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Rational Design of Potent and Selective EGFR Tyrosine Kinase Inhibitors as Anticancer Agents
    Ghosh, Sutapa
    Liu, Xing-Ping
    Zheng, Yaguo
    Uckun, Fatih M.
    CURRENT CANCER DRUG TARGETS, 2001, 1 (02) : 129 - 140
  • [2] Tyrosine kinase inhibitors as anticancer agents
    Matter, A
    ANNALS OF ONCOLOGY, 1998, 9 : 18 - 18
  • [3] Protein tyrosine kinase inhibitors as anticancer agents
    Supuran, CT
    Scozzafava, A
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2004, 14 (01) : 35 - 53
  • [4] Novel Substituted Quinazolines for Potent EGFR Tyrosine Kinase Inhibitors
    Cruz-Lopez, O.
    Conejo-Garcia, A.
    Nunez, M. C.
    Kimatrai, M.
    Garcia-Rubino, M. E.
    Morales, F.
    Gomez-Perez, V.
    Campos, J. M.
    CURRENT MEDICINAL CHEMISTRY, 2011, 18 (07) : 943 - 963
  • [5] Metronidazole acid acyl sulfonamide: A novel class of anticancer agents and potential EGFR tyrosine kinase inhibitors
    Luo, Yin
    Li, Yao
    Qiu, Ke-Ming
    Lu, Xiang
    Fu, Jie
    Zhu, Hai-Liang
    BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (20) : 6069 - 6076
  • [6] Development of the Third Generation EGFR Tyrosine Kinase Inhibitors for Anticancer Therapy
    Cheng, Weiyan
    Zhou, Jianhua
    Tian, Xin
    Zhang, Xiaojian
    CURRENT MEDICINAL CHEMISTRY, 2016, 23 (29) : 3343 - 3359
  • [7] EGFR mutations and EGFR tyrosine kinase inhibitors
    Torri, Valter
    Broggini, Massimo
    Garassino, Marina Chiara
    LANCET ONCOLOGY, 2015, 16 (07): : 746 - 748
  • [8] Recent Advances in the Discovery of Multitargeted Tyrosine Kinase Inhibitors as Anticancer Agents
    Guo, Ting
    Ma, Shutao
    CHEMMEDCHEM, 2021, 16 (04) : 600 - 620
  • [9] Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors as Anticancer Agents
    Fortunato Ciardiello
    Drugs, 2000, 60 : 25 - 32
  • [10] Small molecule tyrosine kinase inhibitors: clinical development of anticancer agents
    Laird, AD
    Cherrington, JM
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2003, 12 (01) : 51 - 64
12345